Dublin, Dec. 09, 2021 (GLOBE NEWSWIRE) -- The "Global Autoimmune Diseases Diagnostics Market (2021-2027) by Product, Test Type, Disease, End-user, and Geography, Impact of Covid-19, Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global Autoimmune Disease Diagnostics Market is estimated to be USD 4.7 Bn in 2021 and is expected to reach USD 8.01 Bn by 2027 growing at a CAGR of 9.3%.

Disorders related to the immune system usually occur due to low activity or overactivity of the immune system. An autoimmune disease is a disorder wherein one's immune system attacks the body and destroys its body tissue. There have been around 80 different types of autoimmune disorders being identified, of which, multiple sclerosis, type 1 diabetes, rheumatoid arthritis are fairly common.

Factors such as a rise in the incidence of autoimmune diseases have been a major driver for the growth of the market of autoimmune drugs. However, the costs associated with the therapeutics is expected to hamper the market growth.

Company Profiles

Market Dynamics

Drivers

Restraints

Opportunities

Trends

Segments Covered

Global Autoimmune Disease Diagnostics Market, By Product

Global Autoimmune Disease Diagnostics Market, By Test Type

Global Autoimmune Disease Diagnostics Market, By Disease

Global Autoimmune Disease Diagnostics Market, By End User

For more information about this report visit https://www.researchandmarkets.com/r/5griwt